Clinical Trial

The clinical trial shows legible positive results for sun-damage skin and reducing of wrinkles with 51% after 3 month.
 
Irrespective of type of skin Jabu’she makes your skin feel younger, smoother and gives it a clearer hue. It increases skin cell activity and strengthens defence against free radicals.
 
Result after 12 weeks:
  • Wrinkles reduced by 51%
  • Skin feels significantly smoother
  • Skin hue is more even and considerably clearer
  • Skin feels younger and has fewer visible pores
Reconstruction of aging and sun-exposed skin presupposes an increased regeneration of cells producing structural components in the cutis such as collagen and elastin.
 
Vitamin A acid, the active form of vitamin A (but not the same thing), stimulates regeneration of such cells.
Unfortunately, vitamin A acid causes side-effects which makes it unsuitable for self-care. For this reason it is only included in prescription drugs.
 
Jabu’she contains QAL 100, a brand new, patented, combination of cooperating substances; Alpha lipoic acid, Coenzyme Q10 and Acetyl-l-Carnitine.
 
Jabu’she with the patented formula QAL-100 is the only skin care concept in the world which has got a clinical trial (with GCP-standard = Good Clinical Partice) published in British Journal of Dermatology (oct 2003).

Conclusions
The first three evaluation methods in the clinical test showed very positive treatment results. These results were confirmed by the fourth evaluation method (laser profilometry) which showed a 51% reduction of eye wrinkles after three month’s usage. Given these results it can be confirmed that Jabu’she with QAL-100 is a breakthrough in obtaining an effective method of treatment of age-related skin problems.

Clinical results after a month
After a month of treatment a clinical evaluation of changes in the skin on each side of the face was conducted by the test supervisor. In all, six parameters were evaluated. The following results were obtained.

Karolinska University Hospital
The trial was managed by skin specialist professor Harry Beitner at Karolinska University Hospital in Stockholm, Sweden.

Klicka här för att logga in